GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Long-Term Liabilities

K Pharma (TSE:4896) Total Long-Term Liabilities : 円31 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. K Pharma's Total Long-Term Liabilities for the quarter that ended in Mar. 2024 was 円31 Mil.

K Pharma Total Long-Term Liabilities Historical Data

The historical data trend for K Pharma's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Total Long-Term Liabilities Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Total Long-Term Liabilities
3.50 4.62 30.65

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Total Long-Term Liabilities Get a 7-Day Free Trial 4.62 30.65 30.65 30.65 31.30

K Pharma Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

K Pharma Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of K Pharma's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Total Long-Term Liabilities
Comparable Companies
TSE:7776 TSE:4888 TSE:4594 TSE:4598 TSE:4588 TSE:4891 TSE:2370 TSE:3750 TSE:4583 TSE:4564 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
Website
https://en.kpharma.co.jp
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines